Summary
Injections of 5,7-dihydroxytryptamine (60 mg/kg, i.p.) caused a significant reduction in the noradrenaline content of the mouse heart, large intestine and seminal vesicle, 2 and 6 days after drug application. The long-lasting depletion of noradrenaline was found to be due to a degeneration of adrenergic nerve terminals as verified by fluorescence and electron microscopical observations.
The results show that 5,7-dihydroxytryptamine is either as potent as (e.g. in the heart) or less potent than 6-hydroxydopamine (e.g. in the vas deferens) in depleting noradrenaline. The pronounced effects of 5,7-dihydroxytryptamine on the adrenergic nerves of the seminal vesicle (supplied by the same short adrenergic neurones as the vas deferens) suggest that 5,7-dihydroxytryptamine may be used as a tool for the induction of a chemical sympathectomy in certain peripheral organs of laboratory animals, supplementary to 6-hydroxydopamine.
Similar content being viewed by others
References
Baumgarten, H. G.: Biogenic monoamines in the cyclostome and lower vertebrate brain. Progr. Histochem. Cytochem. 4, 1 (1972)
Baumgarten, H. G., Björklund, A., Horn, A. S., Schlossberger, H. G.: Studies on the neurotoxic properties of hydroxylated tryptamines. In: Dynamics of Degeneration and growth in neurons. K. Fuxe and Y. Zotterman (Eds.), p. 153–167. Oxford-New York-Braunschweig: Pergamon Press 1974
Baumgarten, H. G., Björklund, A., Lachenmayer, L., Nobin, A.: Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurons in the rat CNS. Acta physiol. scand. Suppl. 391 (1973b)
Baumgarten, G. H., Göthert, M., Holstein, A. F., Schlossberger, H. G.: Chemical sympathectomy induced by 5,6-dihydroxytryptamine Z. Zellforsch. 128, 115–134 (1972)
Baumgarten, H. G., Lachenmayer, L.: 5,7-Dihydroxytryptamine: Improvement in chemical lesioning of indoleamine neurons in the mammalian brain. Z. Zellforsch. 135, 399–414 (1972)
Bjerre, B., Björklund, A., Mobley, W.: A stimulatory effect by nerve growth factor on the regrowth of adrenergic nerve fibres in the mouse peripheral tissues after chemical sympathectomy with 6-hydroxydopamine. Z. Zellforsch. 146, 15–44 (1973)
Björklund, A., Falck, B., Owman, Ch.: Fluorescence microscopic and microspectro-fluorometric techniques for the cellular localization and characterization of biogenic amines. In: I. Kopin (Ed.), Methods in investigative and diagnostic endocrinology, pp. 318–368. Amsterdam: North-Holland Publ. Comp. 1972
Häggendal, J.: An improved method for the fluorimetric determination of small amounts of adrenaline and noradrenaline in plasma and tissues. Acta physiol. scand. 59, 242–254 (1963)
Heikkila, R. E., Mytilineou, L., Côte, L., Cohen, G.: Evidence for degeneration of sympathetic nerve terminals caused by the ortho- and para-quinones of 6-hydroxydopamine. J. Neurochem. 20, 1345–1350 (1973)
Horn, A. S., Baumgarten, H. G., Schlossberger, H. G.: Inhibition of the uptake of 5-hydroxytryptamine, noradrenaline and dopamine into rat brain homogenates by various hydroxylated tryptamines. J. Neurochem. 21, 233–236 (1973)
Iversen, L. L.: Inhibition of catecholamine uptake by 6-hydroxydopamine in rat brain. Europ. J. Pharmacol. 10, 408–410 (1970).
Lachenmayer, L., Groth, H. P.: Degeneration and regeneration of the adrenergic nerves in the rat iris induced by dihydroxytryptamines. Virchows Arch., Abt. B Zellpath. 13, 197–213 (1973)
Luft, J. H.: Improvements in epoxy resin embedding methods. J. biophys. biochem. Cytol. 9, 409–414 (1961)
Lundström, J., Mc.Neil, E. T., Daly, J., Creveling, C. R.: Acute and chronic effects of trihydroxyphenylethylamines and dihydroxytryptamines on adrenergic mechanisms in the murine heart. Fed. Proc. 32, 3126 (1973b)
Lundström, J., Ong, H., Daly, J., Creveling, C. R.: Isomers of 2,4,5-trihydroxyphenylethylamine (6-hydroxydopamine): Longterm effects on the accumulation of (3H)-norepinephrine in mouse heart in vivo. Molec. Pharmacol. 9, 505–513 (1973a)
Shaskan, E. G., Snyder, S. H.: Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J. Pharmacol. exp. Ther. 175, 404–418 (1970)
Thoa, N. B., Eccleston, D., Axelrod, J.: The accumulation of C14-serotonin in the guinea-pig vas deferens. J. Pharmacol. exp. Ther. 169, 68–73 (1969)
Thoenen, H., Tranzer, J. P.: Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 261, 271–288 (1968)
Thoenen, H., Tranzer, J. P.: The pharmacology of 6-hydroxydopamine. Ann. Rev. Pharmacol. 13, 169–180 (1973)
Tranzer, J. P., Thoenen, H.: Selective destruction of adrenergic nerve terminals by chemical analogues of 6-hydroxydopamine. Experientia (Basel) 29, 314–315 (1973)
Tranzer, J. P., Thoenen, H., Snipes, R. L., Richards, J. G.: Recent developments on the ultrastructural aspect of adrenergic nerve endings in various experimental conditions. Prog. Brain Res. 21, 33–46 (1969)
Author information
Authors and Affiliations
Additional information
Supported by grants from the Deutsche Forschungsgemeinschaft.
Rights and permissions
About this article
Cite this article
Baumgarten, H.G., Groth, H.P., Göthert, M. et al. The effect of 5,7-dihydroxytryptamine on peripheral adrenergic nerves in the mouse. Naunyn-Schmiedeberg's Arch. Pharmacol. 282, 245–254 (1974). https://doi.org/10.1007/BF00501233
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00501233